Junsong Yang | Genetics and Gnomics | Research Excellence Award

Prof. Junsong Yang | Genetics and Gnomics | Research Excellence Award

Bengbu Medical University | China

Prof. Junsong Yang, Ph.D., is a Professor at Bengbu Medical University (BBMU), Bengbu, Anhui, China, with nearly two decades of academic and professional service at the institution. He earned his bachelor’s degree in Chemical Process Engineering from East China University of Science and Technology, followed by a Master of Science in Chemistry from the University of Science and Technology of China. He completed his doctoral degree in Chemistry at Anhui University. Over the past eighteen years at BBMU, Professor Yang has been actively engaged in teaching and research, with a strong focus on food quality and safety, contributing to the advancement of applied chemical sciences and public health-oriented education.

Citation Metrics (Scopus)

200
150
100
50
0

Citations
86

Documents
26

h-index
6

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Prof. Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Macau University of Science and Technology | China

Prof. Xinghua (Victor) Pan, PhD, MD, is a distinguished scholar in single-cell technology, genome medicine, cancer biology, regenerative medicine, and multi-omics bioinformatics, currently serving as a Professor at the Precision Regenerative Medicine Research Centre (PRMRC) in the Medical Science Division of Macau University of Science and Technology (MUST), with a secondary affiliation at the State Key Laboratory of Quality Research in Chinese Medicine. A doctoral supervisor in Biomedical Science and Pharmacy programs at MUST, Dr. Pan previously served as Chairman and Professor of Biochemistry and Molecular Biology at Southern Medical University (SMU), where he founded and led the Guangdong Provincial Key Laboratory of Single Cell Technology and Application and held multiple adjunct roles across major hospitals, universities, and national laboratories. With a career spanning Yale University—where he advanced from Associate Research Scientist to Research Scientist and PI-and leadership positions in molecular genomics companies, Dr. Pan brings decades of expertise shaped by rigorous training at Southern Medical University, Fudan University, CAMS & PUMC, and Yale University, complemented by international fellowships at Peking University, Melbourne University, the Ludwig Institute, and Cold Spring Harbor Laboratory. Renowned for pioneering single-cell sequencing innovations-including multiomics, copy-number, methylome, transcriptome, telomere, and multiplexing technologies-he has applied these breakthroughs to major biomedical challenges across cancer, stem cells, organoids, aging, infectious diseases, immunology, brain disorders, and precision medicine. Dr. Pan has authored over 160 publications in high-impact journals such as Nature, PNAS, Advanced Science, Nucleic Acids Research, and Nature Communications, accumulating more than 8,500 citations and an H-index of 40, alongside 15 issued patents in the U.S. and China. His work has been supported by national and international foundations including NSFC, NIH, NSF, MOST, and leading provincial and municipal programs. A dedicated educator who has trained over 60 researchers and taught nearly 10,000 students, he also serves as an Associate Editor of Precision Clinical Medicine and Monocytomics, reviewer for more than 30 top journals, and evaluator for major grant agencies and academic degree committees. As an organizer and keynote speaker at over 100 global conferences, including co-chairing the International Conference on Single Cell and Spatial Omics (TICSSO), Dr. Pan has also held leadership roles in multiple scientific societies and earned numerous accolades such as UICC and CSHL Scholarships, PolyGenomics Fellowship, VEBLEO Fellow, Nanjing Leading Talent, Guangzhou High-Level Talent, Ganpo Distinguished Professor, and the CastUSA Single Cell Genomics Pioneer Award, solidifying his global influence in single-cell biology and precision regenerative medicine.

Profiles: Scopus | Orcid

Featured Publications

"A medium throughput approach for single cell copy number variation sequencing towards efficient application in clinics", Guanchuan Lin; Caiming Chen; Mengchang Xu; Bin Peng; Zhanying Dong; Xuewen Zhou; Jinyu Gao; Jie Yu; Bei Jia; Chen Luo et al., 2025

"Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study",Hongjie Zou; Xinghe Liang; Mengqi Luo; Xinghua Pan; De-Ke Jiang., 2025

"Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis", Yulong Zhang; Yanfang Lu; Liyao Mai; Zebin Wen; Min Dai; Siwen Xu; Xianwei Lin; Yongjian Luo; Yinbin Qiu; Yuting Chen et al., 2025

"Transcriptomics-driven exploration of genetic variation and peptide discovery in the sea anemones Anthopleura midori and Actinia equina",Han Zhang; Xinghua Pan; Chen Weigang., 2025

Dongli Pan | Herpesvirus Infection | Best Researcher Award

Prof. Dr. Dongli Pan | Herpesvirus Infection | Best Researcher Award

Zhejiang University School of Medicine | China

Dr. Prof. Dongli Pan is a distinguished biochemist whose research has significantly advanced the understanding of viral pathogenesis and host-virus interactions. She earned her Ph.D. in Biochemistry from the University of Pennsylvania, Philadelphia (2001–2007), where her dissertation focused on the fast kinetics of tRNA movement on the ribosome during bacterial translation elongation, following a B.S. in Chemistry from Peking University, Beijing (1997–2001). Currently a Professor at the Zhejiang University School of Medicine, Dr. Pan’s major research interests center on the mechanisms of herpes simplex virus (HSV) infection and pathogenesis, HSV-host interactions, and anti-HSV drug development. Her research excellence has been recognized through several competitive national grants, including major projects funded by the National Key R&D Project of China and the National Natural Science Foundation of China, with total funding exceeding several million RMB. Dr. Pan has led and contributed to groundbreaking studies on viral latency, host microRNAs, and innate immune responses to DNA viruses. Before joining Zhejiang University, she conducted postdoctoral research at Harvard Medical School and the University of Pennsylvania, deepening her expertise in molecular virology. In addition to her research, Dr. Pan is a dedicated educator, actively involved in undergraduate and graduate teaching at Zhejiang University and the Zhejiang University–University of Edinburgh Institute, where she organizes and lectures in courses such as Infection 3, Pathogens, and Medical Microbiology and Parasitology, fostering the next generation of biomedical scientists through her bilingual instruction and mentorship.

Profiles: Scopus

Featured Publications

"Inhibitory effect of Alantolactone against varicella-zoster virus in vitro", Virology JournalThis link is disabled., 2025.

"A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing",Nature CommunicationsThis link is disabled., 2025.

"Discovery of Novel Piperazinone-Fused Hydroxypyridinones Inhibiting Herpes Simplex Virus Gene Transcription and Viral Replication", Journal of Medicinal Chemistry, 2025.

"Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells", J. Virol, 2025.